Development of Cancer

breast cancer, lower risk and large study links

A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were about 30% less likely to develop breast cancer. Researchers say the findings are promising but not yet proof,

Secret Life of Mom on MSN · 4h

A large study links GLP-1 use to a 35% lower risk of developing breast cancer

· 7h

Blood Test May Predict Lung Cancer Risk 5 Years Before Diagnosis: Study

Science Daily

One fat helped pancreatic cancer grow while another cut disease in half

A surprising new study suggests that when it comes to pancreatic cancer, the kind of fat you eat may matter more than how ...

New pancreatic cancer pill nearly doubles survival time in breakthrough trial

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...

AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones

AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced a significant milestone in its pancreatic cancer development program, with enrollment of the final subject, barring ...

ascopubs.org

Development of Machine Learning Systems to Predict Cancer-Related Symptoms With Validation Across a Health Care System

Enhancing Readability of Lay Abstracts and Summaries for Urologic Oncology Literature Using Generative Artificial Intelligence: BRIDGE-AI 6 Randomized Controlled Trial We trained and tested ML systems ...

6don MSN

Could cancer vaccines be next? New treatment cuts melanoma risk by nearly 50%

A new mRNA melanoma vaccine from Merck and Moderna showed sustained benefits over five years, cutting the risk of cancer ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results